Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Phosphoramidate derivatives of d4T with improved anti-HIV efficacy retain full activity in thymidine kinase-deficient cells — Christopher McGuigan (1996) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Phosphoramidate derivatives of d4T with improved anti-HIV efficacy retain full activity in thymidine kinase-deficient cells
Shared by
De Clercq Erik
KU Leuven
Phosphoramidate derivatives of d4T with improved anti-HIV efficacy retain full activity in thymidine kinase-deficient cells
Article
1996
en
Authors
+2 more
CM
Christopher McGuigan
DC
Dominique Cahard
HS
Hendrika M. Sheeka
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1996
ChemInform Abstract: Phosphoramidate Derivatives of d4T with Improved anti‐HIV Efficacy Retain Full Activity in Thymidine Kinase‐Deficient Cells.
Christopher McGuigan
,
Dominique Cahard
,
Hendrika M. Sheeka
,
De Clercq Erik
,
Jan Balzarini
Article
1997
Metabolism and anti-HIV activity of phosphoramidate derivatives of D4T-MP with variations in the amino acid moiety
Lieve Naesens
,
Dominique Cahard
,
Antonio Salgado
,
L. Bidois
,
De Clercq Erik
,
Christopher McGuigan
,
Jan Balzarini
Article
1997
Anti-HIV activity and metabolism of phosphoramidate derivatives of D4T-MP with variations in the amino acid moiety
Lieve Naesens
,
Dominique Cahard
,
Antonio Salgado
,
L. Bidois
,
De Clercq Erik
,
Christopher McGuigan
,
Jan Balzarini
Article
1998
Metabolism and Anti-HIV Activity of Phosphoramidate Derivatives of D4T-MP with Variations in the Amino Acid Moiety
Lieve Naesens
,
Dominique Cahard
,
Antonio Salgado
,
L. Bidois
,
De Clercq Erik
,
Christopher McGuigan
,
Jan Balzarini
Article
1996
Aryl Phosphoramidate Derivatives of d4T Have Improved Anti-HIV Efficacy in Tissue Culture and May Act by the Generation of a Novel Intracellular Metabolite
Christopher McGuigan
,
Dominique Cahard
,
Hendrika M. Sheeka
,
De Clercq Erik
,
Jan Balzarini
Discussion(0)
No comments yet. Be the first to comment.